The 55% dividend cut and sharply lowered guidance signal a fundamental shift in TELUS's capital allocation toward deleveraging, which is credit-positive for bondholders but negative for income-focused equity holders. Monitor Q3 2026 results for execution on cost transformation and asset monetization (TELUS Health non-core assets, real estate) to gauge whether the 3.0x leverage target by 2028 is achievable. The removal of the DRIP discount reduces future dilution but also removes a source of equity capital.
Price Chart
Executive Summary
TELUS reported Q2 2026 results with a net loss of $1.8 billion driven by a $2.1 billion non-cash impairment of TELUS Digital goodwill. Consolidated service revenue declined 1% YoY to $4.4 billion and Adjusted EBITDA fell 2% to $1.8 billion. The company slashed its quarterly dividend by 55% to $0.1875/share (annualized $0.75) to prioritize deleveraging, targeting net debt/EBITDA of 3.0x or lower by year-end 2028. Full-year guidance was revised sharply lower: service revenue growth from +2-4% to flat/(2%), Adjusted EBITDA growth from +2-4% to (2%)-(4%), and free cash flow from ~$2.45B to ~$1.8B. The dividend reset and DRIP discount removal are expected to generate ~$2.7B in cumulative cash savings through 2028 for debt reduction. This is a material negative event reflecting deteriorating fundamentals across multiple segments, particularly TELUS Digital, and a significant cut to shareholder returns.
Key Facts
- Net loss of $1.8 billion in Q2 2026 vs net loss of $245 million in Q2 2025, driven by a $2.1 billion non-cash impairment of TELUS Digital goodwill
- Quarterly dividend reset by 55% to $0.1875 per share (annualized $0.75), down from $1.6736 annualized, to generate ~$2.7B in cumulative cash savings through 2028 for deleveraging
- Consolidated service revenue declined 1% YoY to $4.4 billion; Adjusted EBITDA fell 2% to $1.8 billion
- Full-year 2026 guidance revised: service revenue growth from +2-4% to flat/(2%); Adjusted EBITDA growth from +2-4% to (2%)-(4%); free cash flow from ~$2.45B to ~$1.8B
- Net debt to Adjusted EBITDA at 3.5x; targeting 3.0x or lower by year-end 2028 (pushed out from 2027)
- TELUS Digital operating revenues fell 10% YoY to $653M; Adjusted EBITDA down 20% to $72M
- DRIP discount to be removed effective October 1, 2026, reducing shareholder dilution
- Capital expenditures guidance raised to ~$2.6B from ~$2.3B for 2026
Financial Impact
Quarterly dividend cut by 55% from $0.4163 to $0.1875 per share; full-year free cash flow guidance cut by ~$650M from ~$2.45B to ~$1.8B; $2.1B non-cash impairment charge; cumulative cash savings of ~$2.7B from dividend reset through 2028
Risk Factors
- Further deterioration in TELUS Digital revenue and margins as AI automation accelerates client churn in legacy services
- Inability to execute asset monetization (TELUS Health, real estate) at attractive valuations to meet deleveraging targets
- Competitive pricing pressure in Canadian wireless and fixed broadband could further compress ARPU and subscriber growth
- Restructuring costs of ~$900M (revised from ~$500M) may weigh on near-term cash flow and EBITDA
- Potential additional goodwill impairment if TELUS Health partnership monetization triggers reallocation and impairment testing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 12 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (TU) — Batch item 1 | 0001104659-26-088977 |
| Document: tm2615221d3_ex99-1.htm | 0001104659-26-088975 |
| Document: 0001104659-26-088977-index-headers.html | 0001104659-26-088973 |
| Document: 0001104659-26-088977-index.html | 0001104659-26-088977 |
| Document: 0001104659-26-088977.txt | 0001104659-26-088977 |
| 6-K Filing (TU) — Batch item 6 | 0001104659-26-088975 |
| Document: tm2615221d2_6k.htm | 0001104659-26-088977 |
| Document: 0001104659-26-088975-index-headers.html | 0001104659-26-088977 |
| Document: 0001104659-26-088975-index.html | 0001104659-26-088977 |
| Document: 0001104659-26-088975.txt | 0001104659-26-088977 |
| 6-K Filing (TU) — Batch item 11 | 0001104659-26-088973 |
| Document: tu-20260630xex99d2.htm | 0001104659-26-088977 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 31, 2026 9w ago | 6-K | $9.56 $9.67 | ▼ −1.15% | ▲ +1.84% | $8.04 (+15.90%) |
Jun 24, 2026 14w ago | 6-K | $11.23 $10.21 | ▼ −9.08% | ▼ −11.02% | $8.04 (−28.41%) |
Jun 11, 2026 16w ago | Institutional Cluster | $11.89 $10.41 | ▼ −12.45% | ▼ −14.34% | $8.04 (−32.38%) |
May 8, 2026 21w ago | 6-K | $12.75 $12.31 | ▼ −3.45% | ▼ −3.47% | $8.04 (−36.94%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access